Lanean...
Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma
Clear cell renal cell carcinoma (RCC) is characterized by inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene. VHL loss drives tumor angiogenesis and accounts for the clinical activity of VEGF receptor (VEGFR) tyrosine kinase inhibitors (TKIs), the first-line standard of care for advan...
Gorde:
| Argitaratua izan da: | Curr Oncol Rep |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331092/ https://ncbi.nlm.nih.gov/pubmed/28247252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0566-9 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|